US 12161702
Methods and compositions for CNS delivery of heparan N-sulfatase
granted A61KA61K35/76A61K35/761
Quick answer
US patent 12161702 (Methods and compositions for CNS delivery of heparan N-sulfatase) held by Takeda Pharmaceutical Company Limited expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K35/76, A61K35/761, A61K38/46, A61K38/465